معرفی
Sean Pennetti is a Clinical Assistant Professor in Medical Oncology and Hematology at the Yale School of Medicine, with affiliations in Internal Medicine. His research focuses on autoimmune diabetes mechanisms, cancer pathogenesis, and stem cell therapy, particularly in neurodegenerative diseases. He holds an MD from Frank H. Netter SOM at Quinnipiac University, an MS in Pharmacology from Tulane University, and a BS in Neurology from Pennsylvania State University.
Education:
- MD, Frank H. Netter SOM at Quinnipiac University (2019)
- MS in Pharmacology, Tulane University (2012)
- BS in Neurology, Pennsylvania State University (2010)
Research interests include autoimmune diabetes progression, the role of Granulin and TLR-9 in immune dysregulation, and translational studies in prostate cancer and cardiovascular disease. His work employs murine models for in vivo experimentation and molecular analyses such as PCR, flow cytometry, and Western Blotting.
Publications highlight contributions to understanding the pathogenesis of autoimmune diabetes, notably the 2018 paper in JCI Insight on cytidine deaminase deficiency in NOD mice.
No scientific awards are listed, and no grants or advising roles are noted. His collaborative research spans institutions including the University of Pittsburgh and Tulane University, with projects in arteriogenesis, prostate-specific membrane antigen, and Krabbe disease therapy.
